CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.06: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.59%Below 5Y avg (1.14%)
Annual Rate
INR 1.00Paid annual
Payout Ratio
17.5%Sustainable
Last Ex-Dividend
Feb 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
49.76BINR519.93M · vs all stocks (USD)
Trailing P/E
27.48xRevenue (TTM)
25.24BINR263.69M · vs all stocks (USD)
Profit Margin
6.66%Beta
0.4820xvs all stocks
52-Week Change
79.01%vs all stocks
Market Capitalization
49.76BINR519.93M · vs all stocks (USD)
Enterprise Value
45.41BINR474.51M · vs all stocks (USD)
Trailing P/E
27.48xForward P/E
16.18xPrice to Sales (TTM)
1.83xPrice to Book (MRQ)
2.56xEnterprise to Revenue
1.80xEnterprise to EBITDA
14.58xGross Margin
39.90%Profit Margin
6.66%Operating Margin
10.86%Return on Assets (TTM)
5.32%Return on Equity (TTM)
7.65%Revenue (TTM)
25.24BINR263.69M · vs all stocks (USD)
Revenue per Share (TTM)
85.96INRUpdated Aug 21, 2026Quarterly Revenue Growth
37.10%Gross Profit (TTM)
8.93BINR93.32M · vs all stocks (USD)
EBITDA (TTM)
2.90BINR30.34M · vs all stocks (USD)
Net Income (TTM)
1.68BINR17.57M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
89.80%Operating Cash Flow (TTM)
2.14BINR22.39M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.38BINR14.38M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.59%vs all stocks
5-Year Average Dividend Yield
1.14%vs all stocks
Payout Ratio
17.48%Revenue
23.19BINRFY2026 · Mar 31, 2026Cost of Goods Sold
14.87BINRFY2026 · Mar 31, 2026Gross Profit
8.32BINRFY2026 · Mar 31, 2026Operating Income
1.89BINR19.72M · vs all stocks (USD)
Pre-tax Income
1.84BINRFY2026 · Mar 31, 2026Income Tax Expense
467.20MINRFY2026 · Mar 31, 2026Net Income
1.38BINRFY2026 · Mar 31, 2026EBIT
1.99BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
2.90BINRFY2026 · Mar 31, 2026Other Operating Expenses
3.15BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
145.50MINRFY2026 · Mar 31, 2026EPS (Basic)
4.69INRFY2026 · Mar 31, 2026EPS (Diluted)
4.69INRFY2026 · Mar 31, 2026Basic Shares Outstanding
293.48MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
293.48MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
1.02BINRFY2026 · Mar 31, 2026Free Cash Flow
-693.30MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
653.50MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
1.84BINRFY2026 · Mar 31, 2026Other Non-cash Items
11.20MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-734.60MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-104.50MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.71BINRFY2026 · Mar 31, 2026Purchase of Investments
-393.20MINRFY2026 · Mar 31, 2026Other Investing Activity
4.80MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-2.10BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
149.60MINRFY2026 · Mar 31, 2026Common Dividends Paid
-293.50MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-143.90MINRFY2026 · Mar 31, 2026Shares Outstanding
293.53MSharesUpdated Aug 21, 2026Float Shares
82.46MSharesUpdated Aug 21, 2026% Held by Insiders
66.09%vs all stocks
% Held by Institutions
1.49%vs all stocks
Total Cash (MRQ)
2.00BINR20.93M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.82INRUpdated Aug 21, 2026Total Debt (MRQ)
1.35BINR14.15M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0753xCurrent Ratio (MRQ)
1.78xBook Value per Share (MRQ)
61.24INRUpdated Aug 21, 2026Total Assets
25.87BINR270.31M · vs all stocks (USD)
Total Current Assets
12.28BINRFY2026 · Mar 31, 2026Total Liabilities
7.88BINRFY2026 · Mar 31, 2026Total Non-current Assets
13.59BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
982.20MINRFY2026 · Mar 31, 2026Total Current Liabilities
6.90BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
653.50MINRFY2026 · Mar 31, 2026Other Short-term Investments
1.44BINRFY2026 · Mar 31, 2026Accounts Receivable
6.03BINRFY2026 · Mar 31, 2026Inventory
3.71BINRFY2026 · Mar 31, 2026Accounts Payable
4.83BINRFY2026 · Mar 31, 2026Short-term Debt
1.33BINRFY2026 · Mar 31, 2026Other Current Liabilities
181.00MINRFY2026 · Mar 31, 2026Long-term Debt
24.00MINRFY2026 · Mar 31, 2026Common Stock (Book)
587.10MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
17.99BINR187.93M · vs all stocks (USD)
52-Week Low
67.19INRUpdated Aug 21, 202652-Week High
179.60INRUpdated Aug 21, 202652-Week Change
79.01%vs all stocks
Beta
0.4820xvs all stocks
50-Day MA
149.78INRUpdated Aug 21, 2026200-Day MA
102.57INRUpdated Aug 21, 2026Avg 10-Day Volume
3.85MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.44MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
5.71INRUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.06: safe zoneNotable
Altman Z-Score: 5.06
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aim Vaccine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zura Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lifecome Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aquestive Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Arvinas Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharmicell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Wuhan Easydiagnosis Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Bioperfectus Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule